Source: Annual Congress 2005 - Advancements in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Karakatsani, D. Papakosta, A. Rapti, M. Dimadi, A. Markopoulou, P. Latsi, V. Polychronopoulos, G. Birba, E. Serasli, A. Antoniou, A. Papagiannis, C. H. Labrakis, I. Pappa, S. Katsiboula, D. Bouros (Athens, Greece). Incidence and prevalence of interstitial lung diseases in Greece. Eur Respir J 2005; 26: Suppl. 49, 1797

Member's Comments

No comment yet.

Related content which might interest you: Incidence and prevalence of children’s diffuse lung disease in Spain. Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris Source: Eur Respir J, 50 (2) 1602419; 10.1183/13993003.02419-2016 Year: 2017 Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 High prevalence and under-diagnosis of obstructive lung diseases in hospitalized patients in India Source: Eur Respir J 2005; 26: Suppl. 49, 594s Year: 2005 The prevalence and burden of interstitial lung diseases in the USA Source: ERJ Open Res, 8 (1) 00630-2021; 10.1183/23120541.00630-2021 Year: 2022 Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Interstitial lung diseases in Europe Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Epidemiological profile of chronic interstitial lung diseases in Tunisian patients Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Recognition of interstitial lung disease in India Source: Eur Respir J 2007; 30: Suppl. 51, 764s Year: 2007 Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries Source: ERJ Open Res, 8 (1) 00597-2021; 10.1183/23120541.00597-2021 Year: 2022 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 The prevalence of chronic airway diseases in Kirikkale region Source: Eur Respir J 2005; 26: Suppl. 49, 378s Year: 2005 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases Source: International Congress 2016 – Orphan diseases I Year: 2016 Population prevalence and risk factors for chronic bronchitis in India Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Report on the registration of interstitial lung diseases in Spain Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018